• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脂肪含量和肝酶与循环游离和蛋白结合的晚期糖基化终产物相关,后者与低度炎症相关:CODAM 研究。

Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.

机构信息

Department of Internal Medicine, MUMC, Maastricht, Netherlands.

CARIM, MUMC, Maastricht, Netherlands.

出版信息

J Diabetes Res. 2019 May 14;2019:6289831. doi: 10.1155/2019/6289831. eCollection 2019.

DOI:10.1155/2019/6289831
PMID:31218233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6536997/
Abstract

Advanced glycation end products (AGEs) accumulate in fatty livers and may contribute to low-grade inflammation (LGI), potentially via their receptor, RAGE. It is unknown if the AGE accumulation in fatty livers results in elevated circulating AGEs. In a cohort study, we investigated the association of liver fat and hepatocellular damage with circulating AGEs and soluble RAGE (sRAGE) and subsequently the association of circulating AGEs and sRAGE with LGI. Cross-sectional associations of liver fat percentage (eLF%; ln-transformed) and liver enzymes (LE score; standardized) with circulating AGEs (free CML, CEL, and MG-H1 in nM and protein-bound CML, CEL, and pentosidine in nmol/mmol lysine; ln-transformed) and sRAGE (pg/ml, ln-transformed) and additionally of AGEs and sRAGE with LGI (standardized) were determined by multiple linear regression. eLF% was positively associated with circulating free CEL ( = 0.090; 95% CI 0.041; 0.139) but inversely with protein-bound CML ( = -0.071; 95% CI -0.108; -0.034). Similarly, the LE score was positively associated with free CML ( = 0.044; 95% CI 0.012; 0.076) and CEL ( = 0.040; 95% CI 0.009; 0.072) but inversely with protein-bound CML ( = -0.037; 95% CI -0.060; -0.013). Free CML ( = 0.297; 95% CI 0.049; 0.545) was positively associated with LGI, while protein-bound CML ( = -0.547; 95% CI -0.888; -0.207) was inversely associated, although this association was absent after adjustment for BMI. eLF% and LE score were not associated with sRAGE and sRAGE not with LGI after adjustment for BMI. Liver fat and enzymes were positively associated with circulating free AGEs, which were associated with LGI. In contrast, inverse relations were observed of liver fat and enzymes with circulating protein-bound AGEs and of protein-bound AGEs with LGI. These data suggest that hepatic steatosis and inflammation affect the formation and degradation of hepatic protein-bound AGEs resulting in elevated circulating free AGE levels. These alterations in AGE levels might influence LGI, but this is likely independent of RAGE.

摘要

晚期糖基化终产物 (AGEs) 在脂肪性肝脏中蓄积,并可能通过其受体 RAGE 导致低度炎症 (LGI)。目前尚不清楚脂肪性肝脏中 AGE 的蓄积是否会导致循环 AGE 水平升高。在一项队列研究中,我们研究了肝脂肪和肝细胞损伤与循环 AGEs 和可溶性 RAGE (sRAGE) 的相关性,随后研究了循环 AGEs 和 sRAGE 与 LGI 的相关性。通过多元线性回归,确定了肝脂肪百分比 (eLF%;ln 转换) 和肝酶 (LE 评分;标准化) 与循环 AGEs (游离 CML、CEL 和 MG-H1,以 nM 表示;蛋白结合 CML、CEL 和戊糖,以 nmol/mmol 赖氨酸表示;ln 转换) 和 sRAGE (pg/ml,ln 转换) 的横断面相关性,此外还确定了 AGEs 和 sRAGE 与 LGI (标准化) 的相关性。eLF% 与游离 CEL 呈正相关 ( = 0.090;95%CI 0.041;0.139),与蛋白结合 CML 呈负相关 ( = -0.071;95%CI -0.108;-0.034)。同样,LE 评分与游离 CML ( = 0.044;95%CI 0.012;0.076) 和 CEL ( = 0.040;95%CI 0.009;0.072) 呈正相关,但与蛋白结合 CML 呈负相关 ( = -0.037;95%CI -0.060;-0.013)。游离 CML ( = 0.297;95%CI 0.049;0.545) 与 LGI 呈正相关,而蛋白结合 CML ( = -0.547;95%CI -0.888;-0.207) 呈负相关,但在调整 BMI 后,这种相关性不存在。调整 BMI 后,eLF% 和 LE 评分与 sRAGE 无关,sRAGE 与 LGI 无关。肝脂肪和酶与循环游离 AGEs 呈正相关,而游离 AGEs 与 LGI 相关。相反,肝脂肪和酶与循环蛋白结合 AGEs 呈负相关,而蛋白结合 AGEs 与 LGI 呈负相关。这些数据表明,肝脂肪变性和炎症影响肝蛋白结合 AGEs 的形成和降解,导致循环游离 AGE 水平升高。这些 AGE 水平的变化可能会影响 LGI,但这可能与 RAGE 无关。

相似文献

1
Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.肝脂肪含量和肝酶与循环游离和蛋白结合的晚期糖基化终产物相关,后者与低度炎症相关:CODAM 研究。
J Diabetes Res. 2019 May 14;2019:6289831. doi: 10.1155/2019/6289831. eCollection 2019.
2
Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.血清中晚期糖基化终产物(AGEs)和 AGEs 的诱饵可溶性受体(sRAGE)的水平可以在年龄、性别和 BMI 匹配的血糖正常成年人中识别非酒精性脂肪性肝病。
Metabolism. 2018 Jun;83:120-127. doi: 10.1016/j.metabol.2018.01.023. Epub 2018 Feb 2.
3
Protein-Bound Plasma Nε-(Carboxymethyl)lysine Is Inversely Associated With Central Obesity and Inflammation and Significantly Explain a Part of the Central Obesity-Related Increase in Inflammation: The Hoorn and CODAM Studies.血浆蛋白结合型 Nε-(羧甲基)赖氨酸与中心性肥胖和炎症呈负相关,并且可显著解释部分与中心性肥胖相关的炎症增加的原因:Hoorn 和 CODAM 研究。
Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2707-13. doi: 10.1161/ATVBAHA.115.306106. Epub 2015 Oct 8.
4
Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.终末期肾病患者进入肾脏替代治疗过渡期时晚期糖基化终产物和二羰基化合物与血管内皮功能障碍及低度炎症的关系:一项横断面观察性研究。
PLoS One. 2019 Aug 13;14(8):e0221058. doi: 10.1371/journal.pone.0221058. eCollection 2019.
5
Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans.实验性高血糖改变健康肥胖人群循环中氧化应激和糖基化终产物的浓度及其肾清除率。
Nutrients. 2019 Mar 1;11(3):532. doi: 10.3390/nu11030532.
6
Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM.1 型糖尿病患者 overnight fast 后血浆 AGEs 和 sRAGE 同工型的变化差异。
Nutrients. 2019 Feb 13;11(2):386. doi: 10.3390/nu11020386.
7
Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.健康、衰老和身体成分研究中的膳食蛋白质摄入量与循环晚期糖基化终产物/晚期糖基化终产物受体浓度。
Am J Clin Nutr. 2020 Dec 10;112(6):1558-1565. doi: 10.1093/ajcn/nqaa241.
8
Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by N-(carboxymethyl)lysine.Blume 可缓解 N-(羧甲基)赖氨酸促进的非酒精性脂肪肝疾病。
Nutrients. 2024 Jul 19;16(14):2330. doi: 10.3390/nu16142330.
9
Soluble receptor for advanced glycation end products and risk of liver cancer.可溶性晚期糖基化终产物受体与肝癌风险。
Hepatology. 2013 Jun;57(6):2338-45. doi: 10.1002/hep.26264. Epub 2013 May 14.
10
Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.饮食中晚期糖基化终产物的摄入量与血浆和尿液中晚期糖基化终产物水平升高有关:CODAM 研究。
Clin Nutr. 2018 Jun;37(3):919-925. doi: 10.1016/j.clnu.2017.03.019. Epub 2017 Mar 23.

引用本文的文献

1
Is There a Diagnostic Miracle on the Horizon? Emerging Biomarkers in MASLD.是否即将出现诊断奇迹?非酒精性脂肪性肝病中的新兴生物标志物。
J Clin Med. 2025 Aug 30;14(17):6148. doi: 10.3390/jcm14176148.
2
Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study.Forns 指数和脂肪肝指数与血糖、糖尿病前期和 2 型糖尿病的指标相关,但 FIB-4 无关:马斯特里赫特研究分析。
BMJ Open Gastroenterol. 2024 Nov 29;11(1):e001466. doi: 10.1136/bmjgast-2024-001466.
3
Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies.慢性炎症性疾病患者中高密度脂蛋白(HDL)向前β高密度脂蛋白(piHDL)蛋白质组的改变以及针对HDL的疗法
Pharmaceuticals (Basel). 2022 Oct 18;15(10):1278. doi: 10.3390/ph15101278.
4
Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease.甲基乙二醛及其加合物:诱导、修复及与疾病的关联。
Chem Res Toxicol. 2022 Oct 17;35(10):1720-1746. doi: 10.1021/acs.chemrestox.2c00160. Epub 2022 Oct 5.
5
Validation of a Quantification Method for Curcumin Derivatives and Their Hepatoprotective Effects on Nonalcoholic Fatty Liver Disease.姜黄素衍生物定量方法的验证及其对非酒精性脂肪性肝病的肝保护作用
Curr Issues Mol Biol. 2022 Jan 15;44(1):409-432. doi: 10.3390/cimb44010029.
6
Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease.代谢相关脂肪性肝病表型中血脂和脂蛋白谱与肝脂肪含量的变化关系。
Front Endocrinol (Lausanne). 2021 Nov 26;12:691556. doi: 10.3389/fendo.2021.691556. eCollection 2021.
7
A Predictive Model of Metabolic Syndrome by Medical Examination: Evidence from an 8-Year Chinese Cohort.通过医学检查建立的代谢综合征预测模型:来自一个为期8年的中国队列的证据。
Diabetes Metab Syndr Obes. 2021 Nov 8;14:4459-4467. doi: 10.2147/DMSO.S314550. eCollection 2021.
8
Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis.常见非感染性肝病中的晚期糖基化终末产物:系统评价与Meta分析
Nutrients. 2021 Sep 25;13(10):3370. doi: 10.3390/nu13103370.
9
Clinical health markers in dogs fed raw meat-based or commercial extruded kibble diets.生食肉基或商业膨化干粮喂养的犬的临床健康标志物。
J Anim Sci. 2021 Jun 1;99(6). doi: 10.1093/jas/skab133.
10
Toxicity profile of honey and ghee, when taken together in equal ratio.蜂蜜和酥油按等量混合服用时的毒性概况。
Toxicol Rep. 2020 Apr 22;7:624-636. doi: 10.1016/j.toxrep.2020.04.002. eCollection 2020.

本文引用的文献

1
Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease.细胞外基质成分表明人类非酒精性脂肪性肝病不同纤维化阶段的重塑活性。
Histopathology. 2018 Oct;73(4):612-621. doi: 10.1111/his.13665. Epub 2018 Jul 13.
2
Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.血清中晚期糖基化终产物(AGEs)和 AGEs 的诱饵可溶性受体(sRAGE)的水平可以在年龄、性别和 BMI 匹配的血糖正常成年人中识别非酒精性脂肪性肝病。
Metabolism. 2018 Jun;83:120-127. doi: 10.1016/j.metabol.2018.01.023. Epub 2018 Feb 2.
3
Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.饮食中晚期糖基化终产物的摄入量与血浆和尿液中晚期糖基化终产物水平升高有关:CODAM 研究。
Clin Nutr. 2018 Jun;37(3):919-925. doi: 10.1016/j.clnu.2017.03.019. Epub 2017 Mar 23.
4
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.非酒精性脂肪性肝病中氨基酸浓度的改变:肥胖和胰岛素抵抗的影响。
Hepatology. 2018 Jan;67(1):145-158. doi: 10.1002/hep.29465. Epub 2017 Nov 17.
5
Association between metabolically healthy central obesity in women and levels of soluble receptor for advanced glycation end products, soluble vascular adhesion protein-1, and the activity of semicarbazide-sensitive amine oxidase.女性代谢健康型中心性肥胖与晚期糖基化终产物可溶性受体、可溶性血管黏附蛋白-1水平及氨基脲敏感胺氧化酶活性之间的关联
Croat Med J. 2017 Apr 14;58(2):106-116. doi: 10.3325/cmj.2017.58.106.
6
Oxidative Stress and Inflammation in Hepatic Diseases: Current and Future Therapy.肝脏疾病中的氧化应激与炎症:当前与未来的治疗方法
Oxid Med Cell Longev. 2017;2017:3140673. doi: 10.1155/2017/3140673. Epub 2017 Jan 22.
7
Serum Levels of sRAGE Are Associated with Body Measurements, but Not Glycemic Parameters in Patients with Prediabetes.血清sRAGE水平与糖尿病前期患者的身体测量指标相关,但与血糖参数无关。
Metab Syndr Relat Disord. 2016 Feb;14(1):33-9. doi: 10.1089/met.2015.0078. Epub 2015 Nov 16.
8
Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database.采用超高效液相色谱串联质谱法分析特定食品中的晚期糖基化终产物:构建膳食晚期糖基化终产物数据库
Food Chem. 2016 Jan 1;190:1145-1150. doi: 10.1016/j.foodchem.2015.06.049. Epub 2015 Jun 18.
9
A concise review of non-alcoholic fatty liver disease.非酒精性脂肪性肝病简述。
Atherosclerosis. 2015 Mar;239(1):192-202. doi: 10.1016/j.atherosclerosis.2015.01.001. Epub 2015 Jan 13.
10
External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals.使用 1H 磁共振波谱对外脂肝指数和脂滴产品指数进行验证,以在健康对照者和肥胖、胰岛素抵抗个体中识别肝脂肪变性。
Eur J Endocrinol. 2014 Nov;171(5):561-9. doi: 10.1530/EJE-14-0112.